AOK Nordost Die Gesundheitskasse Tender

Contract notice: Conclusion of non-exclusive discount agreements according to §130a paragraph 8 SGB V for various active substance/s/combinations with the possibility of conclusion at any time as part of the so-called open house procedure The subject of this publication is the conclusion of agreements in accordance with Section 130a, Paragraph 8 of the Social Code Book V on various active substances/combinations of active substances as part of what is known as an open house procedure. for details see the respective lot.The subject of this publication is the conclusion of agreements in accordance with Section 130a, Paragraph 8 of the Social Code Book V on various active substances/combinations of active substances as part of what is known as an open house procedure. With the specification of uniform contract conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies will be able to conclude or join a discount contract according to § 130a para. 8 sgb v for the named active substance/active substance combination. After registration, interested pharmaceutical companies can download the order documents (participation documents and contract) from: https://www.dtvp.de/satellite/notice/documents. mail address for the purpose of unrestricted and complete free access to the order documents does not exist. information can only be obtained via your registration on the "dtvp" allocation platform under the communication tab. Information and answers about other bodies are not binding. A prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits the required procedural documents, fully completed and signed. any pharmaceutical company that meets the participation requirements and documents this by signing the declarations and the discount agreement can join the discount agreement. there is no exclusivity. joining or concluding a contract can take place at any time and under the same conditions. individual contract negotiations are not carried out. the start of the contract can only be on the first of the month. The earliest start of the contract is June 1st, 2022. Based on this, the contract term is a maximum of 23 months. the contract ends no later than 04/30/2024, regardless of the date of the conclusion of the contract. if the contract begins on 06/01/2022, the offer must be submitted by 04/25/2022 at the latest; however, no contracts will be concluded by aok nordost before 05/06/2022. for a later start of the contract, the submission deadline for the offers is the 5th of the previous month. (example: contract start 07/01/2022; deadline for submitting the offer: 06/05/2022). should aok nordost award an exclusive contract for the active substance/active substance combination within the framework of an open procedure during the contract period, the closed ones in the context of this publication shall apply contractual regulations. this publicati